Patents by Inventor Justin P. Bzdek

Justin P. Bzdek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electrochemical plasma activated aqueous chemo therapeutics
    Patent number: 11666652
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: June 6, 2023
    Assignee: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS
    Publication number: 20200323982
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 15, 2020
    Applicant: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • Electrochemical plasma activated aqueous chemotherapeutics
    Patent number: 10610590
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: April 7, 2020
    Assignee: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson
  • ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS
    Publication number: 20170312362
    Abstract: Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells.
    Type: Application
    Filed: May 2, 2017
    Publication date: November 2, 2017
    Applicant: Symbios Technologies, Inc.
    Inventors: Brooks M. Hybertson, Jessica M. Joslin, Justin P. Bzdek, Derek C. Johnson